{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T10:07:09Z","timestamp":1779530829933,"version":"3.53.1"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"49","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Government-funded clinical medicine talent project","award":["ZF2024037"],"award-info":[{"award-number":["ZF2024037"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,5]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>\n                      Mixed-phenotype acute leukemia (MPAL) is a type of acute leukemia which is characterized by immunophenotypic features of myeloid, T-lymphoid, and\/or B-lymphoid differentiation. The Philadelphia chromosome-positive (Ph+) MPAL, a rare subtype of MPAL, represents &lt;1% of adult acute leukemia cases and typically has a poor prognosis. Here we report a very unique case of MPAL with Ph\u2005+\u2005atypical\n                      <jats:italic toggle=\"yes\">e13a3 breakpoint cluster region (BCR)::ABL1<\/jats:italic>\n                      fusion protein and provide new perspectives on the diagnosis and management of Ph\u2005+\u2005MPAL.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>We present a 64-year-old male who experienced high-grade fever, nasal congestion, and a runny nose 20 days after contracting a cold. A chest computed tomography revealed double pneumonia. The patient was presented with an anemic appearance, scattered bleeding spots, and ecchymoses, with no superficial lymph nodes palpable.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>\n                      The patient was diagnosed as MPAL with atypical\n                      <jats:italic toggle=\"yes\">e13a3 BCR::ABL1<\/jats:italic>\n                      transcripts by morphology, flow cytometry, cytogenetic and molecular biology analyses.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The patient was treated with a combination therapy of VCD (Bortezomib, Cyclophosphamide, Dexamethasone), Venetoclax, and Dasatinib, supplemented with liver protection, immune modulation, and supportive care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>He achieved remission after 2 lines of therapy but subsequently experienced a sudden relapse 3 months later.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>\n                      At present, there is no established consensus on the treatment of Ph\u2005+\u2005MPAL, and reports on cases with the atypical\n                      <jats:italic toggle=\"yes\">e13a3 BCR::ABL1<\/jats:italic>\n                      fusion are particularly scarce. This finding will bring new insights and references for the diagnosis and treatment of Ph\u2005+\u2005MPAL.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000046329","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T22:01:14Z","timestamp":1764972074000},"page":"e46329","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A case report of mixed-phenotype acute leukemia with atypical BCR::ABL1 e13a3 fusion gene"],"prefix":"10.1097","volume":"104","author":[{"given":"Yan","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, The Second Hospital of Hebei Medical University, Shijiazhuang, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Second Hospital of Hebei Medical University, Shijiazhuang, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7609-6796","authenticated-orcid":false,"given":"Yunlu","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Second Hospital of Hebei Medical University, Shijiazhuang, P.R. China"},{"name":"Department of Cardiovascular Disease, Shinshu University School of Medicine, Matsumoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Second Hospital of Hebei Medical University, Shijiazhuang, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Disease, Shinshu University School of Medicine, Matsumoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanlong","family":"Wang","sequence":"additional","affiliation":[{"name":"SINO-US Diagnostics Lab, Tianjin Enterprise Key Laboratory of AI-aided Hematopathology Diagnosis, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbo","family":"Nie","sequence":"additional","affiliation":[{"name":"SINO-US Diagnostics Lab, Tianjin Enterprise Key Laboratory of AI-aided Hematopathology Diagnosis, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingci","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Second Hospital of Hebei Medical University, Shijiazhuang, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8316-447X","authenticated-orcid":false,"given":"Min","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Second Hospital of Hebei Medical University, Shijiazhuang, P.R. China"},{"name":"Hebei Key Laboratory of Laboratory Medicine, Shijiazhuang, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20260523","doi-asserted-by":"crossref","first-page":"11259","DOI":"10.3390\/ijms231911259","article-title":"Genomic landscape of mixed-phenotype acute leukemia.","volume":"23","author":"Hennawi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R3-20260523","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/cyto.b.21783","article-title":"Multiparameter flow cytometry applications in the diagnosis of mixed phenotype acute leukemia.","volume":"96","author":"Porwit","year":"2019","journal-title":"Cytometry B Clin Cytom"},{"key":"R4-20260523","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/ajcp\/aqac070","article-title":"How I diagnose acute leukemia of ambiguous lineage.","volume":"158","author":"Weinberg","year":"2022","journal-title":"Am J Clin Pathol"},{"key":"R5-20260523","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1172\/JCI33032","article-title":"The legacy of the Philadelphia chromosome.","volume":"117","author":"Koretzky","year":"2007","journal-title":"J Clin Invest"},{"key":"R6-20260523","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40880-016-0108-0","article-title":"The Philadelphia chromosome in leukemogenesis.","volume":"35","author":"Kang","year":"2016","journal-title":"Chin J Cancer"},{"key":"R7-20260523","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1182\/blood-2010-10-314682","article-title":"Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification.","volume":"117","author":"Matutes","year":"2011","journal-title":"Blood"},{"key":"R8-20260523","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1080\/10428190701843247","article-title":"Prognostic implications of the immunophenotype in biphenotypic acute leukemia.","volume":"49","author":"Lee","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"R9-20260523","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(23)00108-3","article-title":"Acute myeloid leukaemia.","volume":"401","author":"DiNardo","year":"2023","journal-title":"Lancet"},{"key":"R10-20260523","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1146\/annurev.me.31.020180.001111","article-title":"Treatment of chronic myeloid leukemia.","volume":"31","author":"Stryckmans","year":"1980","journal-title":"Annu Rev Med"},{"key":"R11-20260523","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/s41375-023-01916-x","article-title":"Mast cell deficiency prevents BCR::ABL1 induced splenomegaly and cytokine elevation in a CML mouse model.","volume":"37","author":"Langhammer","year":"2023","journal-title":"Leukemia"},{"key":"R12-20260523","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/10408363.2020.1829537","article-title":"The genomic and biological complexity of mixed phenotype acute leukemia.","volume":"58","author":"Andrews","year":"2021","journal-title":"Crit Rev Clin Lab Sci"},{"key":"R13-20260523","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/mc.23742","article-title":"Atypical BCR-ABL1 transcript in mixed phenotype acute leukemia with bone marrow necrosis.","volume":"63","author":"Liu","year":"2024","journal-title":"Mol Carcinog"},{"key":"R14-20260523","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s12185-024-03724-0","article-title":"First report of familial mixed phenotype acute leukemia: shared clinical characteristics, Philadelphia translocation, and germline variants.","volume":"119","author":"Shiozawa","year":"2024","journal-title":"Int J Hematol"},{"key":"R15-20260523","first-page":"469","article-title":"Mixed phenotype acute leukaemia with t(9,22), BCR-ABL1: a case report.","volume":"42","author":"Yong","year":"2020","journal-title":"Malays J Pathol"},{"key":"R16-20260523","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00428-015-1802-z","article-title":"BCR-ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR.","volume":"467","author":"Zagaria","year":"2015","journal-title":"Virchows Arch"},{"key":"R17-20260523","first-page":"8486267","article-title":"A Novel BCR::ABL1 variant detected with multiple testing modalities.","volume":"2024","author":"Jean","year":"2024","journal-title":"Case Rep Hematol"},{"key":"R18-20260523","first-page":"9635070","article-title":"Molecular monitoring in adult philadelphia chromosome-positive acute lymphoblastic leukemia with the variant e13a3 BCR-ABL1 fusion.","volume":"2019","author":"Crampe","year":"2019","journal-title":"Case Rep Hematol"},{"key":"R19-20260523","first-page":"5619","article-title":"How to detect the rare BCR-ABL (e14a3) transcript: a case report and literature review.","volume":"14","author":"Hu","year":"2017","journal-title":"Oncol Lett"},{"key":"R20-20260523","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1111\/cas.15501","article-title":"Comparison of molecular responses and outcomes between BCR::ABL1 e14a2 and e13a2 transcripts in chronic myeloid leukemia.","volume":"113","author":"Su","year":"2022","journal-title":"Cancer Sci"},{"key":"R21-20260523","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12308-022-00486-8","article-title":"Mixed phenotype acute leukaemia with monosomy 7 and BCR-ABL1 translocation following antimetabolite therapy for intrahepatic cholangiocarcinoma.","volume":"15","author":"Ray","year":"2022","journal-title":"J Hematop"},{"key":"R22-20260523","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.3390\/biomedicines10081974","article-title":"Mixed-phenotype acute leukemia: clinical diagnosis and therapeutic strategies.","volume":"10","author":"George","year":"2022","journal-title":"Biomedicines"},{"key":"R23-20260523","doi-asserted-by":"crossref","first-page":"107665","DOI":"10.1016\/j.leukres.2025.107665","article-title":"Molecular genetic characterization of mixed-phenotype acute leukemia (MPAL) with BCR::ABL1 fusion.","volume":"151","author":"Shi","year":"2025","journal-title":"Leuk Res"},{"key":"R24-20260523","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0092-8674(94)90407-3","article-title":"The Ikaros gene is required for the development of all lymphoid lineages.","volume":"79","author":"Georgopoulos","year":"1994","journal-title":"Cell"},{"key":"R25-20260523","doi-asserted-by":"crossref","first-page":"102127","DOI":"10.1016\/j.tranon.2024.102127","article-title":"Characterisation of cells markers associated with IKZF1(plus) in BCP-ALL.","volume":"50","author":"Blunck","year":"2024","journal-title":"Transl Oncol"},{"key":"R26-20260523","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3324\/haematol.2012.064485","article-title":"Clinical, immunophenotypic, cytogenetic, and molecular genetic features in 117 adult patients with mixed-phenotype acute leukemia defined by WHO-2008 classification.","volume":"97","author":"Yan","year":"2012","journal-title":"Haematologica"},{"key":"R27-20260523","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1038\/s41467-021-22750-8","article-title":"Cut-like homeobox 1 (CUX1) tumor suppressor gene haploinsufficiency induces apoptosis evasion to sustain myeloid leukemia.","volume":"12","author":"Supper","year":"2021","journal-title":"Nat Commun"},{"key":"R28-20260523","doi-asserted-by":"crossref","first-page":"5914","DOI":"10.1182\/blood-2011-05-356204","article-title":"Somatic mutations in the transcriptional corepressor gene BCORL1 in adult acute myelogenous leukemia.","volume":"118","author":"Li","year":"2011","journal-title":"Blood"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046329","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T10:01:28Z","timestamp":1779530488000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":27,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046329","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"2025-06-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}